Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151

Margaret A. Fischl, Douglas D. Richman, Charles Flexner, Michael F. Para, Richard Haubrich, Aziz Karim, Patrick Yeramian, Jeanne Holden-Wiltse, Patricia M. Meehan

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151'. Together they form a unique fingerprint.

Medicine & Life Sciences